Overview
Klüver-Bucy syndrome (KBS) is a rare neurological disorder resulting from bilateral damage to the temporal lobes of the brain, particularly the amygdalae and surrounding structures. It was first described in rhesus monkeys following bilateral temporal lobectomy and later recognized in humans. The syndrome is not a genetic condition but rather an acquired disorder caused by various underlying conditions, including herpes simplex encephalitis, traumatic brain injury, stroke, Alzheimer's disease, frontotemporal dementia, and other encephalitic or neurodegenerative processes. The syndrome primarily affects the central nervous system and is characterized by a distinctive constellation of behavioral and cognitive symptoms. Key clinical features include hyperorality (a compulsive tendency to examine objects by mouth), visual agnosia (inability to recognize objects or faces), placidity or flattened emotional responses, hypermetamorphosis (an irresistible impulse to react to and explore every visual stimulus), altered dietary habits (including attempts to eat inappropriate objects), and changes in sexual behavior (often hypersexuality or inappropriate sexual conduct). Memory disturbances, particularly amnesia, are also commonly observed. The full syndrome with all classic features is rare in humans; partial forms presenting with only some of these symptoms are more frequently encountered. Treatment of Klüver-Bucy syndrome is primarily directed at the underlying cause and is largely supportive. There is no specific cure for the syndrome itself. Management may include pharmacological interventions such as anticonvulsants (e.g., carbamazepine), selective serotonin reuptake inhibitors (SSRIs), or antipsychotic medications to help manage behavioral disturbances. Behavioral therapy and a structured, safe environment are important components of care. Prognosis varies considerably depending on the underlying etiology; cases caused by encephalitis or trauma may show partial recovery over time, while those associated with progressive neurodegenerative diseases tend to worsen.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Klüver-Bucy syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Klüver-Bucy syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Klüver-Bucy syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Klüver-Bucy syndrome.
Community
No community posts yet. Be the first to share your experience with Klüver-Bucy syndrome.
Start the conversation →Latest news about Klüver-Bucy syndrome
No recent news articles for Klüver-Bucy syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Klüver-Bucy syndrome
What is Klüver-Bucy syndrome?
Klüver-Bucy syndrome (KBS) is a rare neurological disorder resulting from bilateral damage to the temporal lobes of the brain, particularly the amygdalae and surrounding structures. It was first described in rhesus monkeys following bilateral temporal lobectomy and later recognized in humans. The syndrome is not a genetic condition but rather an acquired disorder caused by various underlying conditions, including herpes simplex encephalitis, traumatic brain injury, stroke, Alzheimer's disease, frontotemporal dementia, and other encephalitic or neurodegenerative processes. The syndrome primari
How is Klüver-Bucy syndrome inherited?
Klüver-Bucy syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.